Please login to the form below

Not currently logged in
Email:
Password:

Teva's vice chair steps down

Amir Elstein to take over from Moshe Many
Teva Amir Elstein

Teva faces yet more senior changes as Prof Moshe Many announced his intention to step down as vice chairman at the beginning of next year.

According to Teva, Prof Many is leaving his position for “personal reasons” and will be replaced by board director Amir Elstein. This change will take place on January 1, 2014.

It is second major change at the top for Teva in recent months after the company announced its president and CEO Jeremy Levin was stepping down after just 18 months in the position.

Commenting on Prof Many's decision to step down, Teva's chairman Dr Phillip Frost said: "I would like to thank Prof Many for his outstanding service as vice chairman and wish Amir success in continuing Moshe's good work."

16th December 2013

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

The ALS patient journey
Nick Goldup is the Director of Care Improvement at the Motor Neuron Disease Association (MNDA). Here, he offers his insights into the journey for patients with ALS and explores the...
Equipping your medical affairs teams with solutions to navigate the healthcare landscape
Dr Tyler Ray, OPEN Health Medical Communications...
Protein degraders
Can protein degraders unlock ‘undruggable’ drug targets?
Exploring a new and exciting area of small-molecule drug discovery...

Infographics